16-88429326-G-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001367624.2(ZNF469):c.1856G>T(p.Ser619Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,549,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S619N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001367624.2 missense
Scores
Clinical Significance
Conservation
Publications
- brittle cornea syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
 - brittle cornea syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - aortic disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ZNF469 | NM_001367624.2  | c.1856G>T | p.Ser619Ile | missense_variant | Exon 3 of 3 | ENST00000565624.3 | NP_001354553.1 | |
| ZNF469 | XM_047434810.1  | c.1856G>T | p.Ser619Ile | missense_variant | Exon 4 of 4 | XP_047290766.1 | ||
| LOC112268182 | XR_007065178.1  | n.250+638C>A | intron_variant | Intron 2 of 2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ZNF469 | ENST00000565624.3  | c.1856G>T | p.Ser619Ile | missense_variant | Exon 3 of 3 | 6 | NM_001367624.2 | ENSP00000456500.2 | ||
| ZNF469 | ENST00000437464.1  | c.1856G>T | p.Ser619Ile | missense_variant | Exon 1 of 2 | 5 | ENSP00000402343.1 | 
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152122Hom.:  0  Cov.: 34 show subpopulations 
GnomAD2 exomes  AF:  0.00000672  AC: 1AN: 148824 AF XY:  0.0000125   show subpopulations 
GnomAD4 exome  AF:  0.0000236  AC: 33AN: 1397676Hom.:  0  Cov.: 62 AF XY:  0.0000305  AC XY: 21AN XY: 689344 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152122Hom.:  0  Cov.: 34 AF XY:  0.0000404  AC XY: 3AN XY: 74314 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Cardiovascular phenotype    Uncertain:1 
The p.S619I variant (also known as c.1856G>T), located in coding exon 1 of the ZNF469 gene, results from a G to T substitution at nucleotide position 1856. The serine at codon 619 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Brittle cornea syndrome 1    Uncertain:1 
- -
ZNF469-related disorder    Uncertain:1 
The ZNF469 c.1856G>T variant is predicted to result in the amino acid substitution p.Ser619Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0028% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at